Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice

American Journal of Pathology

Volumn 175, Issue 5, 2009, Pages 1952-1961

  Zattra, Edoardo ^a   Coleman, Christina ^a   Arad, Simin ^a   Helms, Elizabeth ^a   Levine, Danielle ^a   Bord, Evelyn ^b   Guillaume, Alexandra ^a   El Hajahmad, Mohamad ^a   Zwart, Edwin ^c,f   Van Steeg, Harry ^c   Gonzalez, Salvador ^d   Kishore, Raj ^b   Goukassian, David A ^a,b,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Departments of Dermatology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYCLOBUTANE DERIVATIVE; CYCLOBUTANE PYRIMIDE DIMER DERIVATIVE; CYCLOOXYGENASE 2; POLYPODIUM LEUCOTOMOS EXTRACT; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG ACTIVITY; ENZYME INHIBITION; HAIRLESS MOUSE; INFLAMMATION; MACROPHAGE; MALE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION;

EID: 73649085141     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090351     Document Type: Article

References (63)

1. Lewis KG, Weinstock MA: Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 2007, 127:2323-2327
2. Serrano H, Scotto J, Shornick G, Fears TR, Greenberg ER: Incidence of non melanoma skin cancer in New Hampshire and Vermont. Am Acad Dermatol 1991, 4:574-579
3. Goukassian DA, Gilchrest BA: The interdependence of skin aging, skin cancer, and DNA repair capacity: a novel perspective with therapeutic implications. Rejuv Res 2004, 7:175-185
4. Marwaha V, Chen YH, Helms E, Arad S, Inoue H, Bord E, Kishore R, Der Sarkissian R, Gilchrest BA, Goukassian DA: T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through P53-and NFkappa B-dependent repression of the COX-2 promoter. J Biol Chem 2005, 280:32379-32388
5. Middelkamp-Hup MA, Pathak MA, Parrado C, Goukassian D, Rius-Diaz F, Mihm MC, Fitzpatrick TB, Gonzalez S: Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol 2004, 51:910-918
6. Rundhaug JE, Mikulec C, Pavone A, Fischer SM: A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol Carcinogen 2007, 46:692-698
7. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP: COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19:723-729
8. Tripp CS, Blomme EA, Chinn KS, Hardy MM, LaCelle P, Pentland AP: Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J Invest Dermatol 2003, 121:853-861
9. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinogen 1999, 25:231-240
10. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R: Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999, 20:1939-1944
11. Cheuk BL, Leung PS, Lo AC, Wong PY: Androgen control of cyclo-oxygenase expression in the rat epididymis. Biol Reprod 2000, 63:775-780
12. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG: Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res 2001, 61:2720-2726
13. Evans JF, Kargman SL: Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des 2004, 10:627-634
14. Fosslien E: Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001, 31:325-348
15. Gonzalez S, Alonso-Lebrero JL, Del Rio R, Jaen P: Polypodium leucotomos extract: a nutraceutical with photoprotective properties. Drugs Today (Barc) 2007, 43:475-485
16. Sands AT, Abuin A, Sanchez A, Conti CJ, Bradley A: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995, 377:162-165
17. Cheo DL, Ruven HJ, Meira LB, Hammer RE, Burns DK, Tappe NJ, van Zeeland AA, Mullenders LH, Friedberg EC: Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat Res 1997, 374:1-9
18. Tober KL, Wilgus TA, Kusewitt DF, Thomas-Ahner JM, Maruyama T, Oberyszyn TM: Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. J Invest Dermatol 2006, 126:205-211
19. Goukassian DA, Helms E, van Steeg H, van Oostrom C, Bhawan J, Gilchrest BA: Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci USA 2004, 101:3933-3938
20. Allan AE, Archambault M, Messana E, Gilchrest BA: Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol 1995, 105:687-692
21. Boerrigter ME, Dolle ME, Martus HJ, Gossen JA, Vijg J: Plasmid-based transgenic mouse model for studying in vivo mutations. Nature 1995, 377:657-659
22. Park YJ, Lee SH, Jang SJ, Moon DS, Park CY, Chung CH, Cha JH, Lee BR, Choi YH: Myeloperoxidase (MPO) isozymes of normal neutrophils from normal persons and reactive neutrophils from patients with neutrophilia; using 10% native PAGE and activity stain for MPO. Korean J Hematol 2003, 38:48-54
23. Kurushima H, Ramprasad M, Kondratenko N, Foster DM, Quehenberger O, Steinberg D: Surface expression and rapid internalization of macrosialin (mouse CD68) on elicited mouse peritoneal macrophages. J Leukoc Biol 2000, 67:104-108
24. Moriwaki S, Ray S, Tarone RE, Kraemer KH, Grossman L: The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res 1996, 364:117-123
25. van Steeg H, Mullenders LH, Vijg J: Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice. Mutat Res 2000, 450:167-180
26. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T: UV-induced skin damage. Toxicology 2003, 189:21-39
27. Nishigori C, Hattori Y, Toyokuni S: Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004, 6:561-570
28. Achanta G, Huang P: Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res 2004, 64:6233-6239
29. Seo JY, Kim EK, Lee SH, Park KC, Kim KH, Eun HC, Chung JH: Enhanced expression of cylooxygenase-2 by UV in aged human skin in vivo. Mech Ageing Dev 2003, 124:903-910
30. An KP, Athar M, Tang X, Katiyar SK, Russo J, Beech J, Aszterbaum M, Kopelovich L, Epstein EH, Jr., Mukhtar H, Bickers DR: Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol 2002, 76:73-80
31. Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H: Cyclooxygenase-2 expression in hepato-cellular carcinoma. Hepatogastroenterology 1999, 46:407-412
32. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Mas-ferrer J, Koki AT: COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89:2637-2645
33. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ, 3rd: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999, 59:987-990
34. Gombau L, Garcia F, Lahoz A, Fabre M, Roda-Navarro P, Majano P, Alonso-Lebrero JL, Pivel JP, Castell JV, Gomez-Lechon MJ, Gonzalez S: Polypodium leucotomos extract: antioxidant activity and disposition. Toxicol In Vitro 2006, 20:464-471
35. Gonzalez S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB: Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed 1997, 13:50-60
36. Middelkamp-Hup M, Pathak M, Parrado C, Garcia-Caballero T, Rius-Diaz F, Fitzpatrick T, Gonzalez S: Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol 2003, 49:1-9
37. Alonso-Lebrero JL, Dominguez-Jimenez C, Tejedor R, Brieva A, Pivel JP: Photoprotective properties of a hydrophilic extract of the fern Polypodium leucotomos on human skin cells. J Photochem Photobiol B 2003, 70:31-37
38. Janczyk A, Garcia-Lopez MA, Fernandez-Penas P, Alonso-Lebrero JL, Benedicto I, Lopez-Cabrera M, Gonzalez S: A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-alpha and iNOS expression, transcriptional activation and apoptosis. Exp Dermatol 2007, 16:823-829
39. Kastan MB: Wild-type p53: tumors can't stand it. Cell 2007, 128:837-840
40. Nishigori C: Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 2006, 5:208-214
41. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E, Gudkov AV: p53 is a suppressor of inflammatory response in mice. FASEB J 2005, 19:1030-1032
42. Smith ML, Fornace AJ, Jr: p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci USA 1997, 94:12255-12257
43. You YH, Szabo PE, Pfeifer GP: Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors. Carcinogenesis 2000, 21:2113-2117
44. Gallo O, Schiavone N, Papucci L, Sardi I, Magnelli L, Franchi A, Masini E, Capaccioli S: Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. Am J Pathol 2003, 163:723-732
45. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ: Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999, 274:10911-10915
46. Brecher AR: The role of cyclooxygenase-2 in the pathogenesis of skin cancer. J Drugs Dermatol 2002, 1:44-47
47. Dannenberg AJ, Subbaramaiah K: Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003, 4:431-436
48. Koki AT, Masferrer JL: Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002, 9:28-35
49. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ: Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001, 7:429-434
50. Harris RE, Beebe-Donk J, Namboodiri KK: Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Rep 2001, 8:655-657
51. Fischer SM: Is cyclooxygenase-2 important in skin carcinogenesis? J Environ Pathol Toxicol Oncol 2002, 21:183-191
52. Pentland AP: Cyclooxygenase inhibitors for skin cancer prevention: are they beneficial enough? Arch Dermatol 2002, 138:823-824
53. Orengo IF, Gerguis J, Phillips R, Guevara A, Lewis AT, Black HS: Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model. Arch Dermatol 2002, 138:751-755
54. Fischer SM, Conti CJ, Viner J, Aldaz CM, Lubet RA: Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis 2003, 24:945-952
55. Lapane KL, Spooner JJ, Pettitt D: The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Am J Manag Care 2001, 7:402-408
56. Dajani EZ, Islam K: Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. J Physiol Pharmacol 2008, 59 Suppl 2:117-133
57. Fosbol EL, Gislason GH, Jacobsen S, Folke F, Hansen ML, Schramm TK, Sorensen R, Rasmussen JN, Andersen SS, Abildstrom SZ, Traerup J, Poulsen HE, Rasmussen S, Kober L, Torp-Pedersen C: Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009, 85:190-197
58. Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H: Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999, 20:2117-2124
59. Mantena SK, Meeran SM, Elmets CA, Katiyar SK: Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J Nutr 2005, 135:2871-2877
60. Meeran SM, Mantena SK, Elmets CA, Katiyar SK: (-)-Epigallocat-echin-3- gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res 2006, 66:5512-5520
61. Athar M, Agarwal R, Bickers DR, Mukhtar H: Role of reactive oxygen species. Edited by H Mukhtar. Boca Raton, CRC Press Inc., 1992, pp 269-279
62. Dalle Carbonare M, Pathak MA: Skin photosensitizing agents and the role of reactive oxygen species in photoaging. J Photochem Photobiol B 1992, 14:105-124
63. Norris PG, Gange RW, Hawk JLM: Acute effects of ultraviolet radiation on the skin. Edited by TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen. New York, McGraw-Hill, Inc., 1993, pp 1651-1658